Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database AnalysisThe oncologist (Dayton, Ohio), 2022-07, Vol.27 (7), p.573-578 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press. ;COPYRIGHT 2022 Oxford University Press ;The Author(s) 2022. Published by Oxford University Press. 2022 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac049 ;PMID: 35348774Full text available |
|
2 |
Material Type: Article
|
Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysisCanadian Medical Association journal (CMAJ), 2018-07, Vol.190 (26), p.E786-E793 [Peer Reviewed Journal]Joule Inc. or its licensors ;2018 Joule Inc. or its licensors. ;COPYRIGHT 2018 Joule Inc. ;Copyright Joule Inc Jul 3, 2018 ;2018 Joule Inc. or its licensors 2018 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.171333 ;PMID: 29970367Full text available |
|
3 |
Material Type: Article
|
Utility of Low-Dose Duvelisib for Advanced Mycosis Fungoides: A Single-Institution StudyThe oncologist (Dayton, Ohio), 2024-03, Vol.29 (3), p.272 [Peer Reviewed Journal]COPYRIGHT 2024 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/onoolo/oyad345Full text available |
|
4 |
Material Type: Article
|
Management of Abemaciclib‐Associated Adverse Events in Patients with Hormone Receptor‐Positive, Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3The oncologist (Dayton, Ohio), 2021-01, Vol.26 (1), p.e53-e65 [Peer Reviewed Journal]2020 The Authors. published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;2020 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13531 ;PMID: 32955138Full text available |
|
5 |
Material Type: Article
|
Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic GIST: A Phase I/II, Open-Label, Multicenter StudyThe oncologist (Dayton, Ohio), 2023-02, Vol.28 (2), p.187 [Peer Reviewed Journal]COPYRIGHT 2023 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac242Full text available |
|
6 |
Material Type: Article
|
Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto areaCanadian Medical Association journal (CMAJ), 2021-03, Vol.193 (12), p.E410-E418 [Peer Reviewed Journal]2021 Joule Inc. or its licensors. ;COPYRIGHT 2021 Joule Inc. ;Copyright Joule Inc Mar 22, 2021 ;2021 Joule Inc. or its licensors 2021 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.202795 ;PMID: 33568436Full text available |
|
7 |
Material Type: Article
|
Randomized, Double‐Blind, Placebo‐Controlled Phase II Study of Yeast‐Brachyury Vaccine (GI‐6301) in Combination with Standard‐of‐Care Radiotherapy in Locally Advanced, Unresectable ChordomaThe oncologist (Dayton, Ohio), 2021-05, Vol.26 (5), p.e847-e858 [Peer Reviewed Journal]Published 2021. This article is a U.S. Government work and is in the public domain in the USA. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13720 ;PMID: 33594772Full text available |
|
8 |
Material Type: Article
|
Cost-effectiveness of pharmacogenomic-guided treatment for major depressionCanadian Medical Association journal (CMAJ), 2023-11, Vol.195 (44), p.E1499-E1508 [Peer Reviewed Journal]2023 CMA Impact Inc. or its licensors. ;COPYRIGHT 2023 CMA Impact Inc. ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.221785 ;PMID: 37963621Full text available |
|
9 |
Material Type: Article
|
Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on TrastuzumabThe oncologist (Dayton, Ohio), 2023-09, Vol.28 (9), p.e712-e722 [Peer Reviewed Journal]The Author(s) 2023. Published by Oxford University Press. 2023 ;The Author(s) 2023. Published by Oxford University Press. ;COPYRIGHT 2023 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad086 ;PMID: 37094996Full text available |
|
10 |
Material Type: Article
|
Real-World Study of Characteristics and Treatment Outcomes Among Patients with KRAS p.G12C-Mutated or Other KRAS Mutated Metastatic Colorectal CancerThe oncologist (Dayton, Ohio), 2022-08, Vol.27 (8), p.663-674 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press. ;COPYRIGHT 2022 Oxford University Press ;The Author(s) 2022. Published by Oxford University Press. 2022 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac077 ;PMID: 35472176Full text available |
|
11 |
Material Type: Article
|
Treatment Outcomes of Well‐Differentiated High‐Grade Neuroendocrine TumorsThe oncologist (Dayton, Ohio), 2021-05, Vol.26 (5), p.383-388 [Peer Reviewed Journal]2021 AlphaMed Press ;2021 AlphaMed Press. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13686 ;PMID: 33496040Full text available |
|
12 |
Material Type: Article
|
Pexidartinib Long‐Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell TumorsThe oncologist (Dayton, Ohio), 2021-05, Vol.26 (5), p.e863-e873 [Peer Reviewed Journal]2020 The Authors. published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;2020 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13629 ;PMID: 33289960Full text available |
|
13 |
Material Type: Article
|
Serial Assessment of Depression and Anxiety by Patients and Providers in Women Receiving Chemotherapy for Early Breast CancerThe oncologist (Dayton, Ohio), 2021-02, Vol.26 (2), p.147-156 [Peer Reviewed Journal]AlphaMed Press 2020 ;AlphaMed Press 2020. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13528 ;PMID: 32946156Full text available |
|
14 |
Material Type: Article
|
Psychometric findings and normative values for the CLEFT-Q based on 2434 children and young adult patients with cleft lip and/or palate from 12 countriesCanadian Medical Association journal (CMAJ), 2018-04, Vol.190 (15), p.E455-E462 [Peer Reviewed Journal]Joule Inc. or its licensors ;2018 Joule Inc. or its licensors. ;COPYRIGHT 2018 Joule Inc. ;Copyright Joule Inc Apr 16, 2018 ;2018 Joule Inc. or its licensors 2018 ;ISSN: 0820-3946 ;ISSN: 1488-2329 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.170289 ;PMID: 29661814Full text available |
|
15 |
Material Type: Article
|
Safety and Efficacy of Cetuximab‐Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck CancerThe oncologist (Dayton, Ohio), 2021-06, Vol.26 (6), p.e1018-e1035 [Peer Reviewed Journal]2021 AlphaMed Press. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13754 ;PMID: 33751752Full text available |
|
16 |
Material Type: Article
|
Total knee replacement after high tibial osteotomy: time-to-event analysis and predictorsCanadian Medical Association journal (CMAJ), 2021-02, Vol.193 (5), p.E158-E166 [Peer Reviewed Journal]2021 Joule Inc. or its licensors. ;COPYRIGHT 2021 Joule Inc. ;Copyright Joule Inc Feb 1, 2021 ;2021 Joule Inc. or its licensors 2021 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.200934 ;PMID: 33526542Full text available |
|
17 |
Material Type: Article
|
Computed Tomography Texture Analysis for Predicting Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint InhibitorsThe oncologist (Dayton, Ohio), 2022-05, Vol.27 (5), p.389-397 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press. ;COPYRIGHT 2022 Oxford University Press ;The Author(s) 2022. Published by Oxford University Press. 2022 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac034 ;PMID: 35348767Full text available |
|
18 |
Material Type: Article
|
Delayed discharge after major surgical procedures in Ontario, Canada: a population-based cohort studyCanadian Medical Association journal (CMAJ), 2020-11, Vol.192 (46), p.E1440-E1452 [Peer Reviewed Journal]2020 Joule Inc. or its licensors. ;COPYRIGHT 2020 Joule Inc. ;2020 Joule Inc. or its licensors 2020 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.200068 ;PMID: 33199451Full text available |
|
19 |
Material Type: Article
|
Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort StudyThe oncologist (Dayton, Ohio), 2023-06, Vol.28 (6), p.e379-e390 [Peer Reviewed Journal]The Author(s) 2023. Published by Oxford University Press. 2023 ;The Author(s) 2023. Published by Oxford University Press. ;COPYRIGHT 2023 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad001 ;PMID: 36821637Full text available |
|
20 |
Material Type: Article
|
Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II TrialThe oncologist (Dayton, Ohio), 2023-05, Vol.28 (5), p.e254-e262 [Peer Reviewed Journal]The Author(s) 2023. Published by Oxford University Press. 2023 ;The Author(s) 2023. Published by Oxford University Press. ;COPYRIGHT 2023 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac261 ;PMID: 36648325Full text available |